恒瑞医药：子公司药物SHR-A2102纳入突破性治疗品种Available in: 中文2026-04-16T15:38:45.827Z·1 min read♡ 0🔗 Copy link阅读原文：恒瑞医药：子公司药物SHR-A2102纳入突破性治疗品种摘要恒瑞医药：子公司药物SHR-A2102纳入突破性治疗品种来源本文首发于 36kr。阅读原文：恒瑞医药：子公司药物SHR-A2102纳入突破性治疗品种← Previous: [36kr] 永辉超市：一季度净利润2.87亿元，同比增长94.40%Next: [wallstreetcn] 停火延长预期提振市场，美股高开，台积电跌超1%，布油涨2% →Related ArticlesIntel Formally Announces Core Series 3 "Wildcat Lake"2026-04-16T15:48:20.465Z · TechBest MacBook Accessories (2026): Chargers, Covers, Keyboards, and More2026-04-16T15:47:58.253Z · TechLG Sound Suite Review: Big Sound for Larger Rooms2026-04-16T15:47:53.398Z · TechSmart Plug Guide (2026): When You Should and Shouldn’t Use One2026-04-16T15:47:49.899Z · TechThe 10 Best MagSafe Phone Grips for Your Butter Fingers (2026)2026-04-16T15:47:46.562Z · TechComments0Post